The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 12, 2019

Filed:

Jun. 12, 2015
Applicant:

Valerion Therapeutics, Llc, Concord, MA (US);

Inventor:

Dustin D. Armstrong, Quincy, MA (US);

Assignee:

VALERION THERAPEUTICS, LLC, Concord, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/44 (2006.01); C12N 9/34 (2006.01); A61K 38/47 (2006.01); A61K 38/46 (2006.01); C12N 9/26 (2006.01); C12N 9/16 (2006.01); A61K 47/68 (2017.01); A61K 39/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/2428 (2013.01); A61K 38/465 (2013.01); A61K 38/47 (2013.01); A61K 47/6815 (2017.08); A61K 47/6843 (2017.08); C07K 16/44 (2013.01); C12N 9/16 (2013.01); C12N 9/2408 (2013.01); C12Y 301/03016 (2013.01); C12Y 302/0102 (2013.01); C12Y 302/01003 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/55 (2013.01); C07K 2317/622 (2013.01); C07K 2317/77 (2013.01); C07K 2319/00 (2013.01); C07K 2319/10 (2013.01); C07K 2319/30 (2013.01);
Abstract

The present disclosure provides for compositions comprising a chimeric polypeptide comprising a polypeptide effective for treating glycogen storage disease and an internalizing moiety that promotes delivery into cells. In certain embodiments, the polypeptide effective for treating glycogen storage disease is an acid alpha-glucosidase (GAA), a laforin, an amyloglucosidase (AGL), a malin, or an alpha amylase. The present disclosure also provides for methods for decreasing glycogen accumulation in cells or for treating glycogen storage diseases, including Forbes-Cori Disease, Andersen Disease, von Gierke Disease, Pompe Disease, and Lafora Disease, comprising administering the chimeric polypeptide disclosed herein.


Find Patent Forward Citations

Loading…